278 related articles for article (PubMed ID: 11565623)
1. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
[TBL] [Abstract][Full Text] [Related]
2. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
Gil A; Nachum Z; Tal D; Shupak A
Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
[TBL] [Abstract][Full Text] [Related]
3. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
Howland J; Rohsenow DJ; Minsky S; Snoberg J; Tagerud S; Hunt SK; Almeida A; Greece J; Allensworth-Davies D
Int J Occup Environ Health; 2008; 14(4):250-6. PubMed ID: 19043911
[TBL] [Abstract][Full Text] [Related]
4. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
Offenloch K; Zahner G; Dietlein G; Franz I
Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128
[TBL] [Abstract][Full Text] [Related]
5. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
Nachum Z; Shupak A; Gordon CR
Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.
Weerts AP; Pattyn N; Van de Heyning PH; Wuyts FL
J Psychopharmacol; 2014 Jul; 28(7):655-64. PubMed ID: 24346808
[TBL] [Abstract][Full Text] [Related]
7. Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance--a randomized, double-blind, 3-way crossover study in healthy volunteers.
Philipova D; Tzenova B; Iwanowitsch A; Bognar-Steinberg I
Int J Clin Pharmacol Ther; 2004 Apr; 42(4):218-31. PubMed ID: 15124980
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
Pingree BJ; Pethybridge RJ
Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
[TBL] [Abstract][Full Text] [Related]
9. Safety of double-dose transdermal scopolamine.
Bar R; Gil A; Tal D
Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
[TBL] [Abstract][Full Text] [Related]
10. Vestibular evoked myogenic potentials and motion sickness medications.
Tal D; Shemy S; Kaminski-Graif G; Wiener G; Hershkovitz D
Clin Neurophysiol; 2016 Jun; 127(6):2350-4. PubMed ID: 27178852
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
12. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
Noy S; Shapira S; Zilbiger A; Ribak J
Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
[TBL] [Abstract][Full Text] [Related]
13. Transdermal scopolamine: effects of single and repeated patches upon psychological task performance.
Parrott AC
Neuropsychobiology; 1987; 17(1-2):53-9. PubMed ID: 3627392
[TBL] [Abstract][Full Text] [Related]
14. Effects of transdermal scopolamine upon psychological test performance at sea.
Parrott AC; Jones R
Eur J Clin Pharmacol; 1985; 28(4):419-23. PubMed ID: 4029247
[TBL] [Abstract][Full Text] [Related]
15. Influence of 3 antivertiginous medications on the vigilance of healthy volunteers.
Schneider D; Kiessling B; Wieczorek M; Bognar-Steinberg I; Schneider L; Claussen CF
Int J Clin Pharmacol Ther; 2003 Apr; 41(4):171-81. PubMed ID: 12708605
[TBL] [Abstract][Full Text] [Related]
16. The vestibulo-ocular reflex (VOR) under the influence of cinnarizine.
Doweck I; Gordon CR; Spitzer O; Melamed Y; Shupak A
J Vestib Res; 1994; 4(3):215-20. PubMed ID: 7921339
[TBL] [Abstract][Full Text] [Related]
17. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.
Seibel K; Schaffler K; Reitmeir P; Golly I
Arzneimittelforschung; 2002; 52(7):529-36. PubMed ID: 12189776
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
[TBL] [Abstract][Full Text] [Related]
19. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.
Parrott AC
Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072
[TBL] [Abstract][Full Text] [Related]
20. Motion-sickness medications for aircrew: impact on psychomotor performance.
Paul MA; MacLellan M; Gray G
Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
